INGENZA LIMITEDActive
Key figures
Like most small UK companies, INGENZA LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Balance sheet structure
Filed accounts2019/20–2025
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Cash at bank and in hand | 573,734 | 1,309,381 | 780,149 | 2,003,464 | 200,272 |
| Total assets | 3,369,649 | 4,169,991 | 3,831,397 | — | — |
| Total liabilities | 748,933 | 2,038,786 | 1,449,157 | — | — |
| Net assets / total equity | 2,620,716 | 2,131,205 | 2,382,240 | 3,326,922 | 3,263,789 |
| Average number of employees | 38 | 32 | 41 | 47 | 48 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Principal activity
Accounts 2025The principal activity of the company is to provide efficient scalable bioprocesses for its customers to manufacture chemicals, biologics, pharmaceuticals and biofuels from sustainable sources.
As described in the company's latest filed accounts.
Summary: INGENZA LIMITED
Company
INGENZA LIMITED is a private limited company registered with Companies House under company number SC237393. It was incorporated on 26 Sep 2002. Its status is active. The registered office is in Edinburgh technopole (EH26). Its nature of business (SIC 2007) is other professional, scientific and technical activities n.e.c. (74909).
Accounts
The latest accounts in the database are for 2025 (period ending 31 Dec 2025); the company files small company accounts (filleted). Net assets were £3,263,789, down 1.9% on the previous year. Cash at bank and in hand was £200,272. The company had an average of 48 employees. Figures are available for 6 financial years (2019/20–2025).
Control and charges
One person with significant control is registered. 3 of 4 registered charges are outstanding.
Filing deadlines
The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 10 Oct 2026.